| Date | Title | Description |
| 30.03.2026 | PorterShed brings global tech leaders together for Galway event | PorterShed will convene US ecosystem builders, European AI infrastructure leaders and the CEO of Enterprise Ireland in Galway next month for an event focused on the next decade of technology.
Taking place at Dexcom Stadium on 23 April, the ... |
| 11.03.2026 | DeepIP Secures $25M Series B for AI Patent Platform Dominance | DeepIP, the New York and Paris-based AI patent platform, closed a $25 million Series B round. This brings total funding to $40 million. The company embeds AI into patent professionals' existing workflows. It covers the full patent lifecycle... |
| 09.03.2026 | DeepIP: $25 Million Raised For AI Patent Platform | DeepIP, an AI patent platform headquartered in New York City and Paris, has raised $25 million in Series B funding, bringing its total capital raised to $40 million as enterprises increasingly adopt workflow-native AI systems to manage pate... |
| 09.03.2026 | DeepIP Raises $25M in Seires B Funding | DeepIP, a NYC- and Paris, France-based provider of a workflow-native AI platform supporting patent professionals across the patent lifecycle, raised $25M in Series B funding.
The round was led by Korelya and Serena, with participation from ... |
| 03.03.2026 | DeepIP secures $25M Series B to embed AI across the patent lifecycle | AI patent platform DeepIP has raised $25 million in Series B funding, bringing total capital raised to $40 million.
DeepIP is a workflow-native AI platform built to support patent professionals across the full patent lifecycle — from early ... |
| 22.01.2026 | Apple Watch Glucose Monitoring Gets Major Breakthrough | Image: Visual Generation/Envato
Apple Watch has taken a significant step forward with recent developments in blood sugar level monitoring.
When the Apple Watch first launched back in 2015, it was essentially a luxury timepiece with some sma... |
| 11.12.2025 |
Cramer’s Lightning Round: MercadoLibre is a buy | Monday - Friday, 6:00 - 7:00 PM ET
It’s that time again! “Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
Strategy: “I think you should just own Bitc... |
| 04.12.2025 | Listening to Healthcare Professionals: Dexcom Launches New Education Offering, Dexcom Academy | DexCom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced the launch of Dexcom Academy, a new personalised learning platform created with healthcare professionals ... |
| 11.11.2025 | Oura expects close to $2 billion in 2026 sales, almost doubling for the second consecutive year | Smart ring maker Oura raised $900 million in a funding round in October, valuing it at $11 billion.
The Finnish company expects to nearly double its sales in 2026, following investment in AI and international growth.
Oura CEO Tom Hale spoke... |
| 28.10.2025 | Director Declaration | Director Declaration
Tue, Oct 28, 2025 08:05 CET Report this content
28 October 2025
Director Declaration
AstraZeneca PLC (the Company) today announced that Euan Ashley, Non-Executive Director of the Company, has been appointed a director o... |
| 08.09.2025 | Signos Launches First FDA-Cleared Glucose Monitoring System for Weight Management | What You Should Know:
– Signos, a metabolic and weight management company, has announced the launch of the Signos Glucose Monitoring System.
– The system is the first FDA-cleared, over-the-counter glucose monitoring system for weight manage... |
| 06.09.2025 | ViCentra Secures $85 Million to Revolutionize Diabetes Care with Kaleido Patch Pump, Eyes U.S. Market | ViCentra, a European MedTech firm, raised $85 million in Series D funding. This capital will accelerate production and launch of its Kaleido 2 patch pump across Europe. It also prepares for critical U.S. market entry. Kaleido offers a uniqu... |
| 05.09.2025 | Dutch MedTech startup ViCentra raises €72.4 million to scale their Kaleido insulin patch pump | ViCentra, an Utrecht-based medical device company innovating insulin delivery for people with diabetes, announced the successful close of a €72.4 million Series D financing to accelerate manufacturing and launch the Kaleido 2 patch pump in ... |
| 05.09.2025 | ViCentra: $85 Million Raised To Expand Kaleido Patch Pump And Advance Global Diabetes Care | ViCentra, a European medical technology company focused on transforming insulin delivery for people living with diabetes, has announced the close of an $85 million Series D funding round. The round was led by Innovation Industries and inclu... |
| 29.08.2025 | Discuss Debuts “Vibe Coding” and Hybrid AI + Human Market Insight Platform | As AI-moderated interviews reshape qualitative research, many companies frame it as a choice between automation or human connection. Discuss, the only global market insights platform proven to deliver both, today announced new features that... |
| 27.08.2025 | Discuss Introduces “Vibe Coding” and Hybrid AI + Human Market Insight Platform | As AI-moderated interviews reshape qualitative research, many companies frame it as a choice between automation or human connection.
, the only global market insights platform proven to deliver both, announced new features that cement the h... |
| 20.08.2025 | FDA approves first-ever glucose monitoring system for weight loss from Signos | The Food and Drug Administration approved the first-ever glucose monitoring system specifically for weight loss from the startup Signos, a new option for Americans to manage their weight.
Any patient can now purchase a Signos membership to ... |
| 01.08.2025 | Sava Technologies Transforms Health Monitoring with Wearable Biosensor Innovation | Sava Technologies, a London-based MedTech pioneer, secured $19 million in Series A funding. This investment propels its revolutionary wearable biosensor. The device offers pain-free, real-time glucose monitoring. Early clinical trials show ... |
| 31.07.2025 | “Glucose is only the beginning”: London-based Sava Technologies raises €16.6 million for its wearable microsensor technology | Sava Technologies Ltd., a British MedTech startup innovating real-time molecular health monitoring, today announced €16.6 million in Series A funding to accelerate regulatory approval and commercialisation of its next-generation wearable.
T... |
| 18.06.2025 | CeQur® Marks 10 Million Mealtime Injections Replaced and Highlights Commercial Expansion | CeQur Simplicity™
CeQur announces that its wearable insulin patch, CeQur Simplicity™, has replaced 10 million mealtime insulin injections. The company continues its momentum with expanded clinical access and key leadership appointments.
HOR... |
| 06.05.2025 | ŌURA Launches AI-Powered “Meals” & “Glucose” Tracking for Enhanced Metabolic Health | What You Should Know:
– ŌURA, the creator of the leading smart ring, today announced a significant expansion of its health tracking capabilities with the introduction of two new AI-driven metabolic health features: Meals and Glucose.
– Thes... |
| 01.04.2025 | Exclusive: How Dexcom's diabetes technology is changing glucose management | - |
| 06.03.2025 | This insulin delivery system stock at the ‘forefront of innovation’ can jump 25%, RBC says | - |
| 11.02.2025 | Dexcom ONE+ glucose system launches for Type 2 diabetes | - |
| 16.01.2025 | Stagwell (STGW) Acquires ADK GLOBAL, Integrated Marketing Subsidiary of ADK Holdings Inc., Bolstering Growth for the Network Across APAC | Headquartered in Japan, the leading integrated marketing solutions firm will join Stagwell's growing APAC presence, furthering Stagwell's global expansion
NEW YORK and TOKYO, Jan. 16, 2025 /PRNewswire/ -- Stagwell (NASDAQ: STGW), the challe... |
| 20.12.2024 | ŌURA's $200 Million Boost: A New Era for Health Wearables | ŌURA, the innovative force behind the smart ring revolution, has just secured a hefty $200 million in Series D funding. This infusion of capital catapults the company’s valuation to a staggering $5.2 billion. The backing from heavyweights l... |
| 19.12.2024 | ŌURA Raises $200M in Series D Funding | ŌURA, the San Francisco, CA-based company behind Oura Ring, a smart ring, raised $200M in Series D funding.
Backers included Fidelity Management & Research Company and Dexcom. The investment raised the company’s valuation to $5.2 billio... |
| 19.12.2024 | ŌURA: Smart Ring Company Raises $200 Million (Series D) At $5.2 Billion Valuation | ŌURA, the company behind the leading smart ring, Oura Ring, announced today that it has completed a $200 million Series D funding round. Fidelity Management & Research Company and Dexcom, the global leader in glucose biosensing, partici... |
| 19.12.2024 | Smart ring startup Oura nabs $200M at $5.2B valuation
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our mission to provide free, deep, and rel... | Oura Health Oy, the maker of health-tracking smart device Oura Ring, said today it has raised $200 million in a new late-stage funding, doubling its valuation since 2022 to $5.2 billion.
Fidelity Management & Research Co. and DexCom Inc... |
| 06.12.2024 | Liom secures $25 million to advance its non-invasive glucose monitoring device |
Founded in 2017 by serial entrepreneur Leo Grünstein, Liom, with offices in Pfäffikon SZ and San Francisco has raised over USD 55m in equity funding to-date and employs a team of >80 FTE. The company has kicked-off a USD 50-70m Series A... |
| 19.11.2024 | myBiometry: A Breath of Fresh Air for Asthma and COPD Patients | In a world where air can feel heavy, myBiometry emerges as a beacon of hope. This Lowell, Massachusetts-based company has just secured $5 million in seed funding. The investment, led by Dexcom Ventures, with support from CareSource Indiana ... |
| 18.11.2024 | myBiometry: Asthma And COPD Diagnostic Company Raises $5 Million (Seed) | Biometry, an asthma and COPD diagnostic and remote monitoring company, announced that it has raised $5 million in an oversubscribed seed funding round. The funding round was led by Dexcom Ventures, with participation from CareSource Indiana... |
| 28.10.2024 | Apple’s Ambitious Leap into Diabetes Monitoring: A Game Changer on Your Wrist | Apple is on the brink of a health revolution. Imagine a world where your watch not only tells time but also keeps tabs on your blood sugar levels. This isn’t science fiction; it’s the future Apple is crafting. The tech giant is testing a gr... |
| 28.10.2024 | Apple’s big ambitions in health care | Image: Dall-E
Apple, seeking to make further inroads in health care, tested an app this year to help people with pre-diabetes manage their food intake and make lifestyle changes, according to people with knowledge of the matter.
The company... |
| 26.10.2024 | Apple тестирует приложение для контроля уровня сахара в крови | Apple тестирует приложение, которое позволит проверять уровень сахара в крови неинвазивным способом.
Устройство неинвазивного мониторинга глюкозы от Dexcom
Приложение уже опробовали сотрудники компании с преддиабетным состоянием. Параллельн... |
| 26.10.2024 | Future Apple Watches could tell you if you’re at risk for diabetes | An apple a day might keep the doctor away, but an Apple device on your wrist could replace them altogether. Well, sort of. The Apple Watch is already chock-full of health-focused applications, but according to a recent report from Mark Gurm... |
| 14.09.2024 | DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit | NEW YORK, Sept. 14, 2024 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, 2024 and July 25, 2024, both dates inclusive (the "Clas... |
| 14.09.2024 | Производитель умного кольца Oura приобрел стартап в области метаболического здравоохранения Veri | Согласно недавнему заявлению в FCC, старт продаж Oura Ring 4 может произойти со дня на день, сообщает TechCrunch. Тем временем у производителя медицинского оборудования есть еще одна значимая новость. В среду компания Oura объявила о приобр... |
| 11.09.2024 | U.S. and European Patient Monitoring Equipment Market Update: Remote Patient Monitoring, IoT, ASCs, and the Rapid EEG Market | iData Research | VANCOUVER, BC, Sept. 11, 2024 /PRNewswire/ - iData Research, a leading global consulting and market research firm, has released new, in-depth reports on the U.S. and European patient monitoring equipment (PME) markets. The reports highlight... |
| 06.09.2024 | DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit | NEW YORK, Sept. 6, 2024 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of all purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, 2024 ... |
| 05.09.2024 | Dexcom's New Glucose Monitor: A Double-Edged Sword for Investors and Consumers | Dexcom has stepped into the spotlight with its latest product, Stelo, a continuous glucose monitor (CGM) now available over-the-counter. This move is a bold attempt to broaden its market reach beyond diabetes patients. The company aims to t... |
| 05.09.2024 | Type 1 diabetes patients welcome subsidies for glucose monitoring system, but call for more support | Listen to this article
Type 1 diabetes patients welcome subsidies for glucose monitoring system, but call for more support
1 min
New: You can now listen to articles.
This audio is generated by an AI tool.
SINGAPORE: At three years old, Maso... |
| 03.09.2024 | Health | Dexcom starts selling its new over-the-counter glucose monitor. Here’s how much it costs | Dexcom said the use of its continuous glucose monitors on its own or alongside other diabetes or weight management tools can help people understand how different foods or activities affect their glucose levels.
When Dexcom announced the rol... |
| 30.08.2024 | DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit | NEW YORK, Aug. 30, 2024 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of all purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, 2024 ... |
| 28.08.2024 | DexCom's Stelo: A Game Changer for Glucose Monitoring | In a world where health is paramount, DexCom has stepped into the spotlight. The company recently launched Stelo, the first over-the-counter glucose biosensor in the United States. This innovation is a beacon of hope for millions grappling ... |
| 26.08.2024 | DexCom Launches Non-Prescription Glucose Biosensor in U.S. | What You Should Know:
– Millions of Americans with Type 2 diabetes and prediabetes now have a new option for managing their glucose levels.
– DexCom, a leader in continuous glucose monitoring (CGM) technology announced the launch of Stelo, ... |
| 26.08.2024 | DexCom launches Stelo, first over-the-counter glucose biosensor in U.S., available without prescription | DexCom, a maker of real-time continuous glucose monitoring devices, announced today the availability of Stelo, the first over-the-counter glucose biosensor in the U.S., now purchasable without a prescription at Stelo.com. This new offering ... |
| 23.08.2024 | DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit | NEW YORK, Aug. 23, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, 2024 an... |
| 08.08.2024 | Fierce Competition and Technological Innovation Drive Diabetes Care Devices Market Towards Explosive Growth | OEMs Leading the Charge with AI-Equipped Technology and Novel Business Strategies
SAN ANTONIO, Aug. 8, 2024 /PRNewswire/ -- The diabetes care devices industry is witnessing a dynamic evolution, marked by intense competition among establishe... |
| 27.07.2024 | Wall St closes up on revival supported by inflation data, tech stocks | U.S. MarketsWall St closes up on revival supported by inflation data, tech stocks
By David FrenchJuly 26, 202411:31 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
SummaryCompanies
PCE inflation... |
| 21.06.2024 | Locus Health Announces New Integration in Diabetes Health with Dexcom | Locus Logo
Locus’ integration with Dexcom will allow for multiple populations using CGM to integrate their care directly with their healthcare systems EHR.
Glucose is the next vital sign... CGMs have a significant role in patient health, an... |
| 10.06.2024 | Olympic athletes turn to diabetes tech in pursuit of medals | :Olympians including Dutch marathon runner Abdi Nageeye are using a new tool they hope will boost their medal chances this summer: tiny monitors that attach to the skin to track blood glucose levels.
Continuous glucose monitors or CGMs were... |
| 05.06.2024 | Dexcom G7 continuous glucose monitoring system now connects directly to Apple Watch | DexCom has announced that its Dexcom G7 Continuous Glucose Monitoring (CGM) System now connects directly to Apple Watch in the United States. The Dexcom G7 is the first and only CGM system offering real-time glucose readings on the Apple Wa... |
| 22.05.2024 | Nick Jonas shares his top 3 self-care strategies, including one he "used to overlook" | Nick Jonas is a "Sucker" for self-care.
The singer and actor, 31, has a few go-to's when it comes to taking care of his mental health as part of his diabetes management.
"There is that mental health effect that that comes int... |
| 20.05.2024 |
Dexcom launches new sensor in the UK | The ONE+ system, featuring a sensor, reader, smartphone, smartwatch and applicator. [Image courtesy of Dexcom]Dexcom (Nasdaq: DXCM) + announced today that it launched the Dexcom ONE+ continuous glucose monitor (CGM) in the UK.
ONE+ uses Dex... |
| 17.05.2024 | Revolutionizing Obesity Treatment with Precision Medicine | Phenomix Sciences, a cutting-edge biotechnology company, has secured a whopping $7.8 million in funding to accelerate the adoption of precision medicine in the treatment of obesity. This influx of capital, including $5.5 million in Series A... |
| 16.05.2024 | Phenomix Sciences Raises $7.8M to Acclerate Obesity Precision Medicine Adoption | What You Should Know:
– Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, has secured $5.5 million in Series A funding from new investors, DexCom, Inc. and La... |
| 12.03.2024 | Global Continuous Glucose Monitoring (CGM) Devices Market Report 2024-2030 - Sensors Lead Revenue Share, Bluetooth Connectivity Surges, Homecare Segment Accelerates Growth, North America Dominates | - |
| 04.03.2024 | mHealth Market to Surpass USD 70.7 billion by 2032, exhibiting a CAGR of 18% | mhealth Market AMR
PORTLAND, OR, UNITED STATE, March 4, 2024 /EINPresswire.com/ -- The analysts at Allied Market Research have introduced a fresh research study titled "mHealth Market: Global Outlook and Forecast 2023-2032." This ... |
| 14.01.2024 | The best products and ideas at CES 2024 | The DeanBeat | Do you want to get the latest gaming industry news straight to your inbox? Sign up for our daily and weekly newsletters here.
The CES 2023 tech trade show is finally over in Las Vegas, after a grueling six days for me and crowds that number... |
| 24.07.2023 | Revolutionizing Diabetes Management: Dexcom, Andesfit, Veyetals and SenSights.AI Team Up for Advanced Glucose Monitoring | Dexcom CGM integration with SenSights.AI RPM
SenSights.AI integrates FDA-approved Andesfit and Dexcom's CGM, along with Veyetals into its comprehensive RPM Platform for streamlined glucose monitoring
We are the only RPM vendor offering all ... |
| 22.06.2023 | Rimidi Showcases Addition of Glycemic Risk Index to Diabetes Management Platform, Announces Enhanced Integration with Dexcom | GRI is an exciting new tool in the toolkit for clinicians and Rimidi is committed to bringing this innovation into the clinical workflow.
ATLANTA (PRWEB) June 22, 2023
Rimidi, a leading clinical management platform designed to optimize clin... |
| 13.02.2023 | Dexcom G7 Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries at Launch | Dexcom, the global leader in real-time continuous glucose monitoring for people with diabetes, announced its next-generation Dexcom G7 CGM System will be covered for Medicare beneficiaries.† Having met the category requirements for therapeu... |
| 24.01.2023 | Dexcom Ventures Invests in MedCrypt’s Medical Device Cybersecurity Platform | What You Should Know:
The global wearable medical device market size is currently valued at $21.3 billion and is expected to grow 28% by 2030. Cybersecurity remains one of the biggest hurdles for connected devices across all areas of health... |
| 02.12.2022 | DTC Metabolic Tracker Company To Expand Personalized Nutrition Guidance With $62M | Users breathe into the Lumen device in order to get a reading on their metabolism. Based on the results, the connected app will give users a recommendation to follow a low-carb diet that day, a high-carb diet or somewhere in-between.
Wellne... |
| 12.08.2022 | Dexcom Receives FDA Clearance for G7 Continuous Glucose Monitoring (CGM) System | What You Should Know: |
| 08.08.2022 | OTC: ILUS, ILUS International (Ilustrato Pictures International Inc.) Confirms the Settlement of Two $500,000 Notes and Announces a Further $5.6 Million in Funding | NEW YORK, NY, Aug. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- ILUS International Inc. (OTC: ILUS) is a Mergers and Acquisitions company focused on acquiring and developing public safety technology-based companies across the globe. The... |
| 10.05.2022 | Dexcom G7 Blood Glucose Monitoring Launches in 5 Global Markets | What You Should Know:
New features with Dexcom G7 include:
– 60 percent smaller, all-in-one, discreet wearable, developed in partnership with Verily
– 30-minute sensor warm up, fastest of any CGM on the market*
– 12-hour grace period to rep... |
| 07.03.2022 | These 10 medtech companies’ stocks performed best in 2021 | (From Ishant Mishra on Unsplash)
Following a year like no other in 2020, 2021 was when many looked to rebound — including the medtech industry.
A number of medtech companies followed up a challenging, pandemic-enveloped year with impressive... |
| 24.01.2022 | MERCER INTERNATIONAL INC. ANNOUNCES COMPLETION OF CDN$160 MILLION REVOLVING CREDIT FACILITY | NEW YORK, NY - Mercer International Inc., or 'Mercer', (Nasdaq: MERC) announced that certain Canadian subsidiaries (the 'Loan Parties') of Mercer have entered into a new CDN$160 million joint asset-backed revolving credit facility (the 'New... |
| 22.01.2022 | Mercer International Inc. Announces Completion of CDN$160 Million Revolving Credit Facility | NEW YORK, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Mercer International Inc., or "Mercer", (Nasdaq: MERC) today announced that certain Canadian subsidiaries (the "Loan Parties") of Mercer have entered into a new CDN$160 million... |
| 22.01.2022 | Mercer International Inc. Announces Completion of CAD 160 Million Revolving Credit Facility | Mercer International Inc. announced that certain Canadian subsidiaries (the "Loan Parties") of Mercer have entered into a new CAD 160 million joint asset-backed revolving credit facility (the "New Facility") with a syndi... |
| 21.01.2022 | Mercer International Inc. Announces Completion of CDN$160 Million Revolving Credit Facility | NEW YORK, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Mercer International Inc., or "Mercer", (Nasdaq: MERC) today announced that certain Canadian subsidiaries (the "Loan Parties") of Mercer have entered into a new CDN$160 million... |
| 12.01.2022 | Abbott is out to win hearts and minds. Will it one day become a household name? | Rarely do medtech companies have the name recognition that businesses with a closer connection to consumers do. Johnson & Johnson’s name is ubiquitous less for its pure medtech devices than consumer staples like Q-tips, Band-Aids and Ty... |
| 15.12.2021 | Tern : Why invest in IoT stocks? | Crypto may be the tech buzzword of the decade, but IoT is silently eating up market share in investors' pockets. Internet of things (IoT) devices are working their way into every home, warehouse and storeroom at an alarming rate. Help Net S... |
| 10.11.2021 | Signos raises $13M Series A to give you real-time weight-loss advice based on your blood glucose levels | In a world where we count every step and measure every heartbeat, hopping on the scale once per week to keep half an eye on what your body is doing just won’t do. Even if you stand around on the glass oracle of mass a few times per day, the... |
| 28.10.2021 | Dexcom Reports Third Quarter 2021 Financial Results - Form 8-K | Dexcom Reports Third Quarter 2021 Financial Results
SAN DIEGO, CA - (BUSINESS WIRE-October 28, 2021) - DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2021.
Third Quarter 2021 F... |
| 01.10.2021 | OTC: ILUS, ILUS International (Ilustrato Pictures International Inc) Acquisition, BCD Fire, Secures a New Contract Valued at $ 1 Million and Hires 46 New Staff | NEW YORK, NY, Oct. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – ILUS International Inc (OTC: ILUS), ILUS is a M&A company focussed on acquiring and developing technology-based companies globally. The company has already completed fou... |
| 23.09.2021 | Sopharma Trading : expands its portfolio of exclusive brands | Starting September 2021, Sopharma Trading will be partner on the Bulgarian market of the world-famous manufacturer of sensors for continuous measurement of glucose Dexcom. This partnership combines the innovation and high quality of the Cal... |
| 02.09.2021 | Internet of Medical Things: How Connected Devices are Changing Healthcare | The number of connected medical devices – the ones communicating with other systems via the Internet – is growing steadily. These smart things gather and transmit a mountain of healthcare data. Even such small gadgets as fitness trackers an... |
| 11.08.2021 | OTC: ILUS, ILUS International (Ilustrato Pictures International Inc) Acquisition BCD Fire Secures Three New Contracts in the Third Quarter of 2021, Valued at Over $1.5 Million | NEW YORK, NY, Aug. 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- ILUS International Inc (OTC: ILUS) is a M&A company focused on acquiring and developing technology-based companies globally. The company has already completed three acq... |
| 30.07.2021 | Here’s why a job ad has me excited for the Apple Watch of my dreams | The Apple Watch is the smartwatch to beat, with every player in the industry trying to come up with better alternatives. Many wearables look like an Apple Watch from a distance, but they’re not quite as complex. Apple keeps innovating its w... |
| 28.07.2021 | Haynes International, Inc. announces an Equity Buyback for $20 million worth of its shares. | Haynes International, Inc. (NasdaqGS:HAYN) announces a share repurchase program. Under the program, the company will repurchase up to $20 million worth of its common stock. The company will repurchase its shares from the available cash. The... |
| 30.04.2021 | Dexcom stock takes a tumble, despite reporting increased Q1 revenue | Photo by Kwanchai Lerttanapunyaporn/EyeEm/Getty Images |
| 12.02.2021 |
Dexcom Launches Venture Capital Fund
| San Diego-based Dexcom, which develops equipment for continuous glucose monitoring for people with diabetes, has launched its own venture capital fund, Dexcom Ventures. According to Dexcom, the new fund will seek to identify and invest in o... |
| 17.09.2020 | Making the jump from investor to start-up | Author: Tom MoonThe growth of Current Health in 2020 has been astonishing. At the end of 2019 its market-leading remote care platform was well-placed to support the long-term trend of healthcare moving outside the four walls of the hospital... |
| 31.07.2020 | Dexcom makes controlling blood sugar far simpler for diabetes patients — and everyone else too | If you’ve ever wondered if the data we’re amassing will be useful, check out the continuous glucose monitor from the medical device company Dexcom.
As a tech narcissist, I’ve been interested for years in how technology can deliver a “quanti... |
| 31.07.2020 | Dexcom makes controlling blood sugar far simpler for diabetes patients — and everyone else too | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
If you’ve ever wondered if the data we’re amassin... |
| 07.01.2019 | Dexcom, glowing from fabulous results, dismisses Medtronic as a viable CGM competitor at JPM | Dexcom CEO Kevin Sayer was positively beaming as he stood in front of a large audience gathered to hear his presentation at the annual J.P. Morgan Healthcare Conference in San Francisco on Monday.
Fresh off of pre-announcing fourth quarter ... |
| 25.09.2018 | Dexcom Acquires TypeZero Technologies | Dexcom, Inc., a provider of continuous glucose monitoring solutions for people with diabetes, acquired TypeZero Technologies, a Charlottesville, VA-based inControl Diabetes Management Platform startup.
The amount of the deal was not disclos... |
| 10.08.2018 | Dexcom beats revenue guidance, eyes iCGM G6 sales for next quarter's growth | |
| 25.05.2018 | Dexcom outperforms growth expectations but proceeds with caution | Credit: Dexcom |
| 28.03.2018 | FDA clears new Dexcom CGM that requires no patient calibration earlier than expected | The regulatory nod “comes several months ahead of management’s” guidance, wrote Danielle Antalffy, an equity research analyst with Leerink Partners, a healthcare investment bank, in a research note Tuesday after the announcement was made.
B... |
| 06.10.2017 | ScotSoft 2017: Showcasing Scotland To The World | 20 years is a long time when it comes to digital technology. Hardware, programming languages, business models and whole markets have grown, flourished, withered and died in that time. Yet ScotSoft, Scotland’s longest-running digital confere... |
| 07.09.2017 | Fitbit is teaming up with Dexcom for glucose monitoring on the Ionic Smartwatch | Wearable fitness makers are increasingly interested in tracking our vitals. Now Fitbit has announced a collaboration with glucose monitor company Dexcom to develop and market products to help those with diabetes better manage the disease, s... |
| 24.03.2017 | Dexcom will reap benefit as CMS posts criteria for Medicare coverage of CGMs | DexCom, diabetes professional societies, endocrinologists, the American Diabetes Association and the Juvenile Diabetes Research Foundation (JDRF) have been working on this with CMS for years, according to DexCom CEO Kevin Sayer.
“It does ex... |
| 26.10.2016 | ENGAGE: 5 takeaways from MedCity’s patient engagement conference | Many things stood out for me from this year’s event including the widespread acceptance of the value of engagement, expansion of participants across the healthcare ecosystem, diversity of the speakers and participants, the personalization o... |
| 21.10.2016 | This is what deep patient satisfaction looks like | However, once in a while, you run into a situation that cuts through the hype and goes to the heart of what healthcare innovation is striving for every day: deep patient satisfaction.
And so it was at MedCity’s own ENGAGE conference in San ... |
| 17.10.2016 | Wearable health tech firm Dexcom will redefine what is possible in managing personal healthcare | |
| 07.09.2016 | Pharmaceutics International, Inc. (Pii) Receives $93 Million in Growth Capital | HUNT VALLEY, MARYLAND (September 6, 2016) – Pharmaceutics International, Inc. (“Pii”), a contract development and manufacturing organization (“CDMO”) based in Hunt Valley, MD, announced today that it has entered into a definitive agreement ... |
